Cargando…
CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review
BACKGROUND: Artificial intelligence (AI) appears capable of detecting diabetic retinopathy (DR) with a high degree of accuracy in adults; however, there are few studies in children and young adults. METHODS: Children and young adults (3-26 years) with type 1 diabetes mellitus (T1DM) or type 2 diabet...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563496/ https://www.ncbi.nlm.nih.gov/pubmed/37822362 http://dx.doi.org/10.1177/11795514231203867 |
_version_ | 1785118351627911168 |
---|---|
author | Curran, Katie Whitestone, Noelle Zabeen, Bedowra Ahmed, Munir Husain, Lutful Alauddin, Mohammed Hossain, Mohammad Awlad Patnaik, Jennifer L Lanoutee, Gabriella Cherwek, David Hunter Congdon, Nathan Peto, Tunde Jaccard, Nicolas |
author_facet | Curran, Katie Whitestone, Noelle Zabeen, Bedowra Ahmed, Munir Husain, Lutful Alauddin, Mohammed Hossain, Mohammad Awlad Patnaik, Jennifer L Lanoutee, Gabriella Cherwek, David Hunter Congdon, Nathan Peto, Tunde Jaccard, Nicolas |
author_sort | Curran, Katie |
collection | PubMed |
description | BACKGROUND: Artificial intelligence (AI) appears capable of detecting diabetic retinopathy (DR) with a high degree of accuracy in adults; however, there are few studies in children and young adults. METHODS: Children and young adults (3-26 years) with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) were screened at the Dhaka BIRDEM-2 hospital, Bangladesh. All gradable fundus images were uploaded to Cybersight AI for interpretation. Two main outcomes were considered at a patient level: 1) Any DR, defined as mild non-proliferative diabetic retinopathy (NPDR or more severe; and 2) Referable DR, defined as moderate NPDR or more severe. Diagnostic test performance comparing Orbis International’s Cybersight AI with the reference standard, a fully qualified optometrist certified in DR grading, was assessed using the Matthews correlation coefficient (MCC), area under the receiver operating characteristic curve (AUC-ROC), area under the precision-recall curve (AUC-PR), sensitivity, specificity, positive and negative predictive values. RESULTS: Among 1274 participants (53.1% female, mean age 16.7 years), 19.4% (n = 247) had any DR according to AI. For referable DR, 2.35% (n = 30) were detected by AI. The sensitivity and specificity of AI for any DR were 75.5% (CI 69.7-81.3%) and 91.8% (CI 90.2-93.5%) respectively, and for referable DR, these values were 84.2% (CI 67.8-100%) and 98.9% (CI 98.3%-99.5%). The MCC, AUC-ROC and the AUC-PR for referable DR were 63.4, 91.2 and 76.2% respectively. AI was most successful in accurately classifying younger children with shorter duration of diabetes. CONCLUSIONS: Cybersight AI accurately detected any DR and referable DR among children and young adults, despite its algorithms having been trained on adults. The observed high specificity is particularly important to avoid over-referral in low-resource settings. AI may be an effective tool to reduce demands on scarce physician resources for the care of children with diabetes in low-resource settings. |
format | Online Article Text |
id | pubmed-10563496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-105634962023-10-11 CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review Curran, Katie Whitestone, Noelle Zabeen, Bedowra Ahmed, Munir Husain, Lutful Alauddin, Mohammed Hossain, Mohammad Awlad Patnaik, Jennifer L Lanoutee, Gabriella Cherwek, David Hunter Congdon, Nathan Peto, Tunde Jaccard, Nicolas Clin Med Insights Endocrinol Diabetes Original Research BACKGROUND: Artificial intelligence (AI) appears capable of detecting diabetic retinopathy (DR) with a high degree of accuracy in adults; however, there are few studies in children and young adults. METHODS: Children and young adults (3-26 years) with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) were screened at the Dhaka BIRDEM-2 hospital, Bangladesh. All gradable fundus images were uploaded to Cybersight AI for interpretation. Two main outcomes were considered at a patient level: 1) Any DR, defined as mild non-proliferative diabetic retinopathy (NPDR or more severe; and 2) Referable DR, defined as moderate NPDR or more severe. Diagnostic test performance comparing Orbis International’s Cybersight AI with the reference standard, a fully qualified optometrist certified in DR grading, was assessed using the Matthews correlation coefficient (MCC), area under the receiver operating characteristic curve (AUC-ROC), area under the precision-recall curve (AUC-PR), sensitivity, specificity, positive and negative predictive values. RESULTS: Among 1274 participants (53.1% female, mean age 16.7 years), 19.4% (n = 247) had any DR according to AI. For referable DR, 2.35% (n = 30) were detected by AI. The sensitivity and specificity of AI for any DR were 75.5% (CI 69.7-81.3%) and 91.8% (CI 90.2-93.5%) respectively, and for referable DR, these values were 84.2% (CI 67.8-100%) and 98.9% (CI 98.3%-99.5%). The MCC, AUC-ROC and the AUC-PR for referable DR were 63.4, 91.2 and 76.2% respectively. AI was most successful in accurately classifying younger children with shorter duration of diabetes. CONCLUSIONS: Cybersight AI accurately detected any DR and referable DR among children and young adults, despite its algorithms having been trained on adults. The observed high specificity is particularly important to avoid over-referral in low-resource settings. AI may be an effective tool to reduce demands on scarce physician resources for the care of children with diabetes in low-resource settings. SAGE Publications 2023-10-09 /pmc/articles/PMC10563496/ /pubmed/37822362 http://dx.doi.org/10.1177/11795514231203867 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Curran, Katie Whitestone, Noelle Zabeen, Bedowra Ahmed, Munir Husain, Lutful Alauddin, Mohammed Hossain, Mohammad Awlad Patnaik, Jennifer L Lanoutee, Gabriella Cherwek, David Hunter Congdon, Nathan Peto, Tunde Jaccard, Nicolas CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review |
title | CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review |
title_full | CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review |
title_fullStr | CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review |
title_full_unstemmed | CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review |
title_short | CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review |
title_sort | childstar: children living with diabetes see and thrive with ai review |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563496/ https://www.ncbi.nlm.nih.gov/pubmed/37822362 http://dx.doi.org/10.1177/11795514231203867 |
work_keys_str_mv | AT currankatie childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT whitestonenoelle childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT zabeenbedowra childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT ahmedmunir childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT husainlutful childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT alauddinmohammed childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT hossainmohammadawlad childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT patnaikjenniferl childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT lanouteegabriella childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT cherwekdavidhunter childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT congdonnathan childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT petotunde childstarchildrenlivingwithdiabetesseeandthrivewithaireview AT jaccardnicolas childstarchildrenlivingwithdiabetesseeandthrivewithaireview |